The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist. Issue 1 (February 2018)

Record Type:
Journal Article
Title:
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist. Issue 1 (February 2018)
Main Title:
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist
Authors:
Di Matteo, S.
Nevi, L.
Costantini, D.
Colantonio, M.
Giulitti, F.
Napoletano, C.
Safarikia, S.
Manzi, E.
Derose, A.M.
Melandro, F.
Bragazzi, M.C.
Grazi, G.
Berloco, P.B.
Giuliante, F.
Carpino, G.
Cardinale, V.
Gaudio, E.
Alvaro, D.
Abstract:
Is Part Of:
Digestive and liver disease. Volume 50:Issue 1(2018)Supplement
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Issue Display:
Volume 50, Issue 1 (2018)
Year:
2018
Volume:
50
Issue:
1
Issue Sort Value:
2018-0050-0001-0000
Page Start:
22
Page End:
23
Publication Date:
2018-02
Subjects:
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:
http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.dld.2018.01.082 ↗
Languages:
English
ISSNs:
1590-8658
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
5869.xml